The aim of our study was to demonstrate the frequency of FGFR3 mutation in different tumor stages of cystectomy samples, and to reveal a possible relationship between the FGFR status, PD-L1 status, CPS score, tumour-stages and the survival of patients. The gene discussed is CD274; the disease is neoplasm.